Academic Section(s):
Infectious Diseases
Education:
2014 - 2018 Doctor of Pharmacy
University of Texas, Austin, TX
Board Certification(s):
Board Certified Infectious Diseases Pharmacist (BCIDP)
Residency:
2018 - 2019 Pharmacy Resident
Intermountain Medical Center, Intermountain
Healthcare, Murray, UT
2019 - 2020 Infectious Diseases Pharmacy Resident
Maine Medical Center, Mainehealth, Portland, ME
Select Publications:
Siegrist, E. A., Sassine, J. (2022). Antivirals with Activity Against Monkeypox: A Clinically Oriented Review. Clinical Infectious Diseases. PMID: 35904001. DOI: 10.1093/cid/ciac622
Siegrist, E. A., Sassine, J. (2022). Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Intensive Care Medicine, 48(7), 963-964. PMID:35616656. DOI: https://doi.org/10.1007/s00134-022-06754-6.
White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21(9):1208-1209. doi:10.1016/S1473-3099(21)00456-4.
Siegrist EA, Wungwattana M, Azis L, et al. Limited clinical utility of follow-up blood cultures in patients with streptococcal bacteremia: An opportunity for blood culture stewardship. Open Forum Infectious Disease. 2020;7(12).
Leal J, Dong T, Taylor A, Siegrist EA, Gao F, Smyth HDC, Ghosh D. Mucus-penetrating phage-displayed peptides for improved transport across a mucus-like model. Int J Pharmaceutics. 2018;553(1-2):57-64.